Aβ toxicity in Alzheimer's disease

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer's Disease (AD) is a leading cause of age-related neurodegeneration.
• Key pathological hallmarks include amyloid plaques, neurofibrillary tangles, and significant neuronal loss.
• Dendritic spine loss strongly correlates with cognitive impairment in AD patients.

Purpose of the Study:

• To investigate the role of amyloid-beta (Aβ) peptide in Alzheimer's Disease pathogenesis.
• To elucidate the mechanisms by which Aβ impairs neuronal function, particularly synaptic integrity.
• To identify potential therapeutic targets for preventing neurodegeneration in AD.

Main Methods:

• Review of existing evidence on Aβ neurotoxicity and its correlation with disease progression.
• Focus on the impact of soluble Aβ oligomers versus insoluble fibrils.
• Examination of Aβ's potential targeting of mitochondrial function.

Main Results:

• Soluble Aβ oligomers, not insoluble fibrils, are strongly implicated in AD progression.
• Aβ accumulation disrupts synaptic function, potentially by targeting mitochondria.
• Imbalances in Aβ production, aggregation, and clearance contribute to pathological levels.

Conclusions:

• Aβ peptide is a central player in AD neurotoxicity.
• Understanding Aβ-induced synaptic impairment is vital for developing effective AD therapies.
• Targeting Aβ mechanisms offers a promising avenue for pharmacological intervention in AD.